Aurisco Pharmaceutical Co Ltd
SSE:605116
Aurisco Pharmaceutical Co Ltd
Revenue
Aurisco Pharmaceutical Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Aurisco Pharmaceutical Co Ltd
SSE:605116
|
Revenue
¥1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Revenue
¥31.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥22.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
See Also
What is Aurisco Pharmaceutical Co Ltd's Revenue?
Revenue
1B
CNY
Based on the financial report for Dec 31, 2022, Aurisco Pharmaceutical Co Ltd's Revenue amounts to 1B CNY.
What is Aurisco Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
13%
Over the last year, the Revenue growth was 25%. The average annual Revenue growth rates for Aurisco Pharmaceutical Co Ltd have been 20% over the past three years , 13% over the past five years .